MCT2D is excited to announce the release of two new handouts focused on the urine albumin-to-creatinine ratio (uACR) test, a key measure for detecting early kidney damage in people living with type 2 diabetes.
For Patients

For People Living with Type 2 Diabetes Urine Albumin-to-Creatinine Ratio (uACR) Test
This handout is designed for patients and caregivers. It explains:
What the uACR test is: a simple urine test that measures protein levels to detect early kidney damage.
Why it matters: early detection helps protect kidney and heart health.
How often to test: at least once a year, or more often if recommended by your care team.
What you can do: manage blood sugar, blood pressure, medications, and healthy lifestyle choices
For Clinicians

For Clinicians Treating Type 2 Diabetes
Urine Albumin-to-Creatinine
Ratio (uACR) Test
This resource supports providers in discussing and ordering the uACR test. It includes:
Definitions of albumin, creatinine, and uACR.
Explanation of why the ratio (not just albumin) is critical for accurate results.
Information on uACR values and their clinical implications for kidney and cardiovascular health
Help us improve this new resource!
2 Minute Feedback SurveyCompleting this survey fulfills your Primary Care Physician-Level Learning Community VBR requirement for 2025-2026.
Developed by Kidney Experts
Both tools were co-authored by the MCT2D Kidney Initiative leads: Michael Heung, MD, MS – Program Director
Rajiv Saran, MD, MBBS, MS – Nephrology Content Expert
Julie Wright Nunes, MD, MPH – Nephrology Content Expert
These new resources are part of MCT2D’s ongoing commitment to improving kidney health and diabetes care across Michigan.